Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-[2-(2-fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C18H14FN3O. It belongs to the class of phenylpyridines and is catalogued as DrugBank DB07728. The drug has been studied experimentally as an inhibitor of MAP kinase-activated protein kinases (notably MAPKAPK2 and MAPKAPK3), which are downstream effectors in the mitogen-activated protein kinase signaling pathway. There are no approved indications or clinical trials reported for this compound; it remains an experimental agent with no known therapeutic use or marketed products[1][2][3].
- Other names
- DB07728DB-07728DB 07728Kinome_2487KS6A4_HUMANKS6A5_HUMANMAP kinase-activated protein kinase 2 inhibitor (experimental)MAP kinase-activated protein kinase 3 inhibitor (experimental)
02
Targets
MAPKAPK3 (MAP kinase-activated protein kinase 3)MK2 (Mitogen-activated protein kinase-activated protein kinase 2)
Beyond the preview
Go deeper on 2-[2-(2-fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-[2-(2-fluorophenyl)pyridin-4-yl]-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one.